MicroRNA‑874 is downregulated in cervical cancer and inhibits cancer progression by directly targeting ETS1 Retraction in /10.3892/or.2022.8380

Liao,Haihong; Pan,Yunfei; Pan,Yuefen; Shen,Junjun; Qi,Quan; Zhong,Liping; Han,Wenshu; Wang,Qi; Jiang,Yizhen

doi:10.3892/or.2018.6624

MicroRNA‑874 is downregulated in cervical cancer and inhibits cancer progression by directly targeting ETS1

Retraction in: /10.3892/or.2022.8380

Authors:
- Haihong Liao
- Yunfei Pan
- Yuefen Pan
- Junjun Shen
- Quan Qi
- Liping Zhong
- Wenshu Han
- Qi Wang
- Yizhen Jiang
View Affiliations

Affiliations: Department of Medical Oncology, Huzhou Central Hospital, Huzhou, Zhejiang 313000, P.R. China, Department of Medical Oncology, Huzhou Central Hospital, Huzhou, Zhejiang 313000, P.R. China
Published online on: August 2, 2018 https://doi.org/10.3892/or.2018.6624
Pages: 2389-2398

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

An increasing number of studies have reported that microRNAs (miRNAs) are dysregulated in cervical cancer and serve critical roles in cervical oncogenesis and progression. Therefore, identifying the aberrantly expressed miRNAs implicated in the formation and progression of cervical cancer may provide key clues for the development of effective therapeutic targets in treating patients with this type of malignancy. In the present study, miRNA‑874 (miR‑874) was downregulated in cervical cancer tissues and cell lines, and this downregulation was associated with International Federation of Gynaecology and Obstetrics stage and lymph node metastasis. The restored expression of miR‑874 prohibited the proliferation, migration and invasion, but promoted the apoptosis of cervical cancer cells. In addition, E26 transformation specific‑1 (ETS1) was identified as the direct target of miR‑874 in cervical cancer. Inhibition of ETS1 served tumour‑suppressive roles similar to miR‑874 overexpression in cervical cancer cells. A series of rescue experiments revealed that restoring ETS1 expression abolished the tumour‑suppressing effects of miR‑874 in cervical cancer cells. Taken together, the results of the present study indicated that miR‑874 may serve as a tumour suppressor in cervical cancer by directly targeting ETS1. This function suggested that miR‑874 holds potential therapeutic applications in treating patients with this type of malignancy.

View Figures

View References

1	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
2	Arbyn M, Castellsagué X, de Sanjosé S, Bruni L, Saraiya M, Bray F and Ferlay J: Worldwide burden of cervical cancer in 2008. Ann Oncol. 22:2675–2686. 2011. View Article : Google Scholar : PubMed/NCBI
3	Marth C, Landoni F, Mahner S, McCormack M, Gonzalez-Martin A and Colombo N: Cervical cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 28:iv72–iv83. 2017. View Article : Google Scholar : PubMed/NCBI
4	Seoud M, Tjalma WA and Ronsse V: Cervical adenocarcinoma: Moving towards better prevention. Vaccine. 29:9148–9158. 2011. View Article : Google Scholar : PubMed/NCBI
5	Kogo R, How C, Chaudary N, Bruce J, Shi W, Hill RP, Zahedi P, Yip KW and Liu FF: The microRNA-218~Survivin axis regulates migration, invasion, and lymph node metastasis in cervical cancer. Oncotarget. 6:1090–1100. 2015. View Article : Google Scholar : PubMed/NCBI
6	Matsukura T and Sugase M: Pitfalls in the epidemiologic classification of human papillomavirus types associated with cervical cancer using polymerase chain reaction: Driver and passenger. Int J Gynecol Cancer. 18:1042–1050. 2008. View Article : Google Scholar : PubMed/NCBI
7	He L and Hannon GJ: MicroRNAs: Small RNAs with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004. View Article : Google Scholar : PubMed/NCBI
8	Bartel DP: MicroRNAs: Target recognition and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
9	Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
10	Macfarlane LA and Murphy PR: MicroRNA: Biogenesis, function and role in cancer. Curr Genomics. 11:537–561. 2010. View Article : Google Scholar : PubMed/NCBI
11	Kent OA and Mendell JT: A small piece in the cancer puzzle: MicroRNAs as tumor suppressors and oncogenes. Oncogene. 25:6188–6196. 2006. View Article : Google Scholar : PubMed/NCBI
12	Shi X, Yuan N, Zhang S, Yuan F and Wang X: MicroRNA-379 suppresses cervical cancer cell proliferation and invasion by directly targeting V-crk avian sarcoma virus CT10 oncogene homolog-like. Oncol Res. Jan 2–2018.(Epub ahead of print). doi: 10.3727/096504017X15140534417184. View Article : Google Scholar
13	Teng P, Jiao Y, Hao M and Tang X: microRNA-383 suppresses the PI3K-AKT-MTOR signaling pathway to inhibit development of cervical cancer via down-regulating PARP2. J Cell Biochem. 119:5243–5252. 2018. View Article : Google Scholar : PubMed/NCBI
14	Zhou LL, Shen Y, Gong JM, Sun P and Sheng JH: MicroRNA-466 with tumor markers for cervical cancer screening. Oncotarget. 8:70821–70827. 2017.PubMed/NCBI
15	Wang Z, He S, Guo P, Guo X and Zheng J: MicroRNA-1297 inhibits metastasis and epithelial-mesenchymal transition by targeting AEG-1 in cervical cancer. Oncol Rep. 38:3121–3129. 2017. View Article : Google Scholar : PubMed/NCBI
16	Mei J, Wang DH, Wang LL, Chen Q, Pan LL and Xia L: MicroRNA-200c suppressed cervical cancer cell metastasis and growth via targeting MAP4K4. Eur Rev Med Pharmacol Sci. 22:623–631. 2018.PubMed/NCBI
17	Zhang Z, Wang J, Wang X, Song W, Shi Y and Zhang L: MicroRNA-21 promotes proliferation, migration, and invasion of cervical cancer through targeting TIMP3. Arch Gynecol Obstet. 297:433–442. 2018. View Article : Google Scholar : PubMed/NCBI
18	Han J, Liu Z, Wang N and Pan W: MicroRNA-874 inhibits growth, induces apoptosis and reverses chemoresistance in colorectal cancer by targeting X-linked inhibitor of apoptosis protein. Oncol Rep. 36:542–550. 2016. View Article : Google Scholar : PubMed/NCBI
19	Dong D, Gong Y, Zhang D, Bao H and Gu G: miR-874 suppresses the proliferation and metastasis of osteosarcoma by targeting E2F3. Tumour Biol. 37:6447–6455. 2016. View Article : Google Scholar : PubMed/NCBI
20	Zhang Y, Wei Y, Li X, Liang X, Wang L, Song J, Zhang X, Zhang C, Niu J, Zhang P, et al: microRNA-874 suppresses tumor proliferation and metastasis in hepatocellular carcinoma by targeting the DOR/EGFR/ERK pathway. Cell Death Dis. 9:1302018. View Article : Google Scholar : PubMed/NCBI
21	Jiang B, Li Z, Zhang W, Wang H, Zhi X, Feng J, Chen Z, Zhu Y, Yang L, Xu H and Xu Z: miR-874 inhibits cell proliferation, migration and invasion through targeting aquaporin-3 in gastric cancer. J Gastroenterol. 49:1011–1025. 2014. View Article : Google Scholar : PubMed/NCBI
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2^−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
23	Granados-López AJ, Ruiz-Carrillo JL, Servín-González LS, Martínez-Rodríguez JL, Reyes-Estrada CA, Gutiérrez-Hernández R and López JA: Use of mature miRNA strand selection in miRNAs families in cervical cancer development. Int J Mol Sci. 18:E4072017. View Article : Google Scholar : PubMed/NCBI
24	Li J, Liu Q, Clark LH, Qiu H, Bae-Jump VL and Zhou C: Deregulated miRNAs in human cervical cancer: Functional importance and potential clinical use. Future Oncol. 13:743–753. 2017. View Article : Google Scholar : PubMed/NCBI
25	Dai S, Lu Y, Long Y, Lai Y, Du P, Ding N and Yao D: Prognostic value of microRNAs in cervical carcinoma: A systematic review and meta-analysis. Oncotarget. 7:35369–35378. 2016. View Article : Google Scholar : PubMed/NCBI
26	Zhao B and Dong AS: MiR-874 inhibits cell growth and induces apoptosis by targeting STAT3 in human colorectal cancer cells. Eur Rev Med Pharmacol Sci. 20:269–277. 2016.PubMed/NCBI
27	Que K, Tong Y, Que G, Li L, Lin H, Huang S, Wang R and Tang L: Downregulation of miR-874-3p promotes chemotherapeutic resistance in colorectal cancer via inactivation of the Hippo signaling pathway. Oncol Rep. 38:3376–3386. 2017.PubMed/NCBI
28	Jiang T, Guan LY, Ye YS, Liu HY and Li R: MiR-874 inhibits metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma by targeting SOX12. Am J Cancer Res. 7:1310–1321. 2017.PubMed/NCBI
29	Leong KW, Cheng CW, Wong CM, Ng IO, Kwong YL and Tse E: miR-874-3p is down-regulated in hepatocellular carcinoma and negatively regulates PIN1 expression. Oncotarget. 8:11343–11355. 2017. View Article : Google Scholar : PubMed/NCBI
30	Zhang X, Tang J, Zhi X, Xie K, Wang W, Li Z, Zhu Y, Yang L, Xu H and Xu Z: miR-874 functions as a tumor suppressor by inhibiting angiogenesis through STAT3/VEGF-A pathway in gastric cancer. Oncotarget. 6:1605–1617. 2015.PubMed/NCBI
31	Lin Z, Liu Y, Sun Y and He X: Expression of Ets-1, Ang-2 and maspin in ovarian cancer and their role in tumor angiogenesis. J Exp Clin Cancer Res. 30:312011. View Article : Google Scholar : PubMed/NCBI
32	Tokuhara K, Ogata Y, Nakagawa M and Shirouzu K: Ets-1 expression in vascular endothelial cells as an angiogenic and prognostic factor in colorectal carcinoma. Int Surg. 88:25–33. 2003.PubMed/NCBI
33	Xu S, Ge J, Zhang Z and Zhou W: MiR-129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancer. Biomed Pharmacother. 96:634–641. 2017. View Article : Google Scholar : PubMed/NCBI
34	Zheng L, Qi T, Yang D, Qi M, Li D, Xiang X, Huang K and Tong Q: microRNA-9 suppresses the proliferation, invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1. PLoS One. 8:e557192013. View Article : Google Scholar : PubMed/NCBI
35	Xu FL, Li YL, Wang ZD and Feng YJ: Expression and significance about VEGF, KDR, MMP-1, and transcription factor Ets-1 in human cervical carcinoma. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 25:396–400. 2003.(In Chinese). PubMed/NCBI
36	Fujimoto J, Aoki I, Toyoki H, Khatun S and Tamaya T: Clinical implications of expression of ETS-1 related to angiogenesis in uterine cervical cancers. Ann Oncol. 13:1598–1604. 2002. View Article : Google Scholar : PubMed/NCBI
37	Tomar S, Plotnik JP, Haley J, Scantland J, Dasari S, Sheikh Z, Emerson R, Lenz D, Hollenhorst PC and Mitra AK: ETS1 induction by the microenvironment promotes ovarian cancer metastasis through focal adhesion kinase. Cancer Lett. 414:190–204. 2018. View Article : Google Scholar : PubMed/NCBI
38	Wu M, Liu X, Jin W, Li Y, Li Y, Hu Q, Chu PK, Tang G and Ping Y: Targeting ETS1 with RNAi-based supramolecular nanoassemblies for multidrug-resistant breast cancer therapy. J Control Release. 253:110–121. 2017. View Article : Google Scholar : PubMed/NCBI
39	Zhang SY, Lu ZM, Lin YF, Chen LS, Luo XN, Song XH, Chen SH and Wu YL: miR-144-3p, a tumor suppressive microRNA targeting ETS-1 in laryngeal squamous cell carcinoma. Oncotarget. 7:11637–11650. 2016.PubMed/NCBI